Everence Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Hold |
1,920
| – | – | 0.02% | 595 |
|
|
2025
Q1 | $289K | Hold |
1,920
| – | – | 0.02% | 580 |
|
|
2024
Q4 | $354K | Buy |
+1,920
| New | +$354K | 0.02% | 497 |
|
|
2024
Q3 | – | Sell |
-1,600
| Closed | -$366 | – | 770 |
|
|
2024
Q2 | $366 | Hold |
1,600
| – | – | 0.03% | 473 |
|
|
2024
Q1 | $434 | Hold |
1,600
| – | – | 0.03% | 454 |
|
|
2023
Q4 | $378K | Buy |
+1,600
| New | +$378K | 0.03% | 502 |
|
|
2022
Q4 | – | Sell |
-2,140
| Closed | -$421K | – | 754 |
|
|
2022
Q3 | $421K | Hold |
2,140
| – | – | 0.04% | 397 |
|
|
2022
Q2 | $458K | Hold |
2,140
| – | – | 0.04% | 372 |
|
|
2022
Q1 | $608K | Hold |
2,140
| – | – | 0.05% | 324 |
|
|
2021
Q4 | $806K | Buy |
+2,140
| New | +$806K | 0.06% | 268 |
|